JP2022553653A5 - - Google Patents
Info
- Publication number
- JP2022553653A5 JP2022553653A5 JP2022521684A JP2022521684A JP2022553653A5 JP 2022553653 A5 JP2022553653 A5 JP 2022553653A5 JP 2022521684 A JP2022521684 A JP 2022521684A JP 2022521684 A JP2022521684 A JP 2022521684A JP 2022553653 A5 JP2022553653 A5 JP 2022553653A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation according
- weight
- highly lipophilic
- physiologically active
- cannabinoid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025169943A JP2025182116A (ja) | 2019-10-16 | 2025-10-08 | 高親油性生理活性物質の放出制御製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19203580.6A EP3808341A1 (de) | 2019-10-16 | 2019-10-16 | Kontrolliert freisetzende formulierungen stark lipophiler physiologisch aktiver substanzen |
| EP19203580.6 | 2019-10-16 | ||
| PCT/EP2020/079248 WO2021074403A1 (de) | 2019-10-16 | 2020-10-16 | Kontrolliert freisetzende formulierungen stark lipophiler physiologisch aktiver substanzen |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025169943A Division JP2025182116A (ja) | 2019-10-16 | 2025-10-08 | 高親油性生理活性物質の放出制御製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022553653A JP2022553653A (ja) | 2022-12-26 |
| JP2022553653A5 true JP2022553653A5 (https=) | 2023-10-19 |
| JP7778069B2 JP7778069B2 (ja) | 2025-12-01 |
Family
ID=68281185
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521684A Active JP7778069B2 (ja) | 2019-10-16 | 2020-10-16 | 高親油性生理活性物質の放出制御製剤 |
| JP2025169943A Pending JP2025182116A (ja) | 2019-10-16 | 2025-10-08 | 高親油性生理活性物質の放出制御製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025169943A Pending JP2025182116A (ja) | 2019-10-16 | 2025-10-08 | 高親油性生理活性物質の放出制御製剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240139215A1 (https=) |
| EP (2) | EP3808341A1 (https=) |
| JP (2) | JP7778069B2 (https=) |
| CN (1) | CN114945353A (https=) |
| AU (1) | AU2020365443A1 (https=) |
| BR (1) | BR112022006643A2 (https=) |
| CA (1) | CA3157654A1 (https=) |
| IL (1) | IL292018A (https=) |
| MX (1) | MX2022004523A (https=) |
| WO (1) | WO2021074403A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3808336A1 (de) * | 2019-10-16 | 2021-04-21 | ADD Advanced Drug Delivery Technologies, Ltd. | Kontrolliert freisetzende formulierungen stark lipophiler physiologisch aktiver substanzen |
| CA3205594A1 (en) | 2020-12-17 | 2022-06-23 | Nalu Bio, Inc. | Synthesis of cannabidiol and analogs thereof, and related compounds, formulations, and methods of use |
| GB2618322A (en) * | 2022-04-29 | 2023-11-08 | 113 Botanicals Ltd | Compositions and methods |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1361864T3 (en) * | 2001-02-14 | 2014-03-03 | Gw Pharma Ltd | FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids |
| EP1364646A4 (en) | 2001-03-01 | 2005-08-03 | Grelan Pharmaceutical Co | FENOFIBRATE CONTAINING COMPOSITION |
| DE10226494A1 (de) * | 2002-06-14 | 2004-01-08 | Lts Lohmann Therapie-Systeme Ag | Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen |
| WO2008024490A2 (en) | 2006-08-24 | 2008-02-28 | Theraquest Biosciences, Inc. | Oral pharmaceutical formulations of abuse deterrent cannabinoids and method of use |
| CA2929321C (en) | 2013-10-29 | 2022-04-05 | Echo Pharmaceuticals B.V. | Compressed tablet containing cannabidiol, method for its manufacture and use of such tablet in oral treatment of psychosis or anxiety disorders |
| DE102014213548A1 (de) * | 2014-07-11 | 2016-01-14 | Hans Brammer | Cannabispräparat |
| RS67855B1 (sr) * | 2014-08-11 | 2026-03-31 | Woerwag Pharma Gmbh & Co Kg | Formulacija koja sadrži čestice |
| IL246790A0 (en) | 2016-07-14 | 2016-09-29 | Friedman Doron | Self-dissolving compounds of cannabinoids |
| WO2018035030A1 (en) | 2016-08-15 | 2018-02-22 | Corr-Jensen Inc. | Time release fat-soluble actives |
| JP2019137614A (ja) | 2018-02-06 | 2019-08-22 | 富士フイルム株式会社 | 経口用医薬組成物及びその製造方法 |
| DE102019100483A1 (de) * | 2019-01-10 | 2020-07-16 | Lts Lohmann Therapie-Systeme Ag | Oraler Dünnfilm |
-
2019
- 2019-10-16 EP EP19203580.6A patent/EP3808341A1/de not_active Withdrawn
-
2020
- 2020-10-16 AU AU2020365443A patent/AU2020365443A1/en active Pending
- 2020-10-16 MX MX2022004523A patent/MX2022004523A/es unknown
- 2020-10-16 WO PCT/EP2020/079248 patent/WO2021074403A1/de not_active Ceased
- 2020-10-16 IL IL292018A patent/IL292018A/en unknown
- 2020-10-16 EP EP20800800.3A patent/EP4045014A1/de active Pending
- 2020-10-16 CN CN202080072328.8A patent/CN114945353A/zh active Pending
- 2020-10-16 BR BR112022006643A patent/BR112022006643A2/pt unknown
- 2020-10-16 CA CA3157654A patent/CA3157654A1/en active Pending
- 2020-10-16 JP JP2022521684A patent/JP7778069B2/ja active Active
- 2020-10-16 US US17/769,424 patent/US20240139215A1/en active Pending
-
2025
- 2025-10-08 JP JP2025169943A patent/JP2025182116A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022553653A5 (https=) | ||
| ME01944B (me) | Farmaceutske kompozicije koje sadrže rozuvastatin kalcijum | |
| JP2025182116A5 (https=) | ||
| JP2005511641A (ja) | ショウガ抽出物製剤 | |
| EP4115896A1 (fr) | Extrait de plante très concentré en safranal, procédé d'obtention et utilisations | |
| JP6641062B2 (ja) | テコビリマットの経口用医薬組成物及びその調製法 | |
| CN110833531B (zh) | 一种维生素e制剂及其制备方法 | |
| JP2025182116A (ja) | 高親油性生理活性物質の放出制御製剤 | |
| EP1994926B9 (en) | Valsartan formulations | |
| CN103385876B (zh) | 一种夫罗曲坦的药物组合物及其制备方法 | |
| KR102349893B1 (ko) | 제약 투여 형태 | |
| JPWO2019004449A1 (ja) | 医薬組成物 | |
| JP2022553652A5 (https=) | ||
| Bala et al. | Natural gums and mucilage as matrix formers in sustained released dosage forms | |
| JP2020525424A (ja) | テルミナリア・アルジュナの樹皮からのアルジュングルコシドの標準化組成物の調製のための方法 | |
| JP2009501214A (ja) | クロピドグレルビスルファートを含有する薬学的組成物 | |
| JP5698395B2 (ja) | 結晶及び該結晶を含有してなる医薬製剤 | |
| Al-Pokhiti et al. | Development and evaluation of sustained release matrix tablets of ketoprofen employing natural polymers (pomegranate peel and acacia powders) | |
| CN107137384A (zh) | 紫草素在制备治疗肺癌药物中的应用 | |
| CN115715764B (zh) | 一种阿帕替尼口腔贴片及其制备方法 | |
| CA2259730A1 (en) | Sustained release tablets containing bupropion hydrochloride | |
| KR102760108B1 (ko) | 수용해도와 투과도를 향상시켜 생체이용률이 개선된 무정형 아픽사반 고체분산체 제제 및 그의 서방성 정제 | |
| CN101222929A (zh) | 银杏提取物 | |
| AU2020366134B2 (en) | Controlled release formulations of highly lipophilic physiologically active substances | |
| Reddy et al. | Conception and Evaluation of Gemfibrozil as Immediate Drug Delivery System |